Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (151-160 of 518) with videos related to

Pageof 52
Sort By:
The Journal of Clinical Psychiatry|November 15, 2011
International consensus group on depression prevention in bipolar disorderMark A Frye, Kyooseob Ha, Shigenobu Kanba, et al.
Journal of Clinical Psychopharmacology|August 22, 2013
A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depressionMark A Frye, Jon O Ebbert, Courtney A Prince, et al.
Biology of Sex Differences|December 11, 2019
Statistical methods for testing X chromosome variant associations: application to sex-specific characteristics of bipolar disorderWilliam A Jons, Colin L Colby, Susan L McElroy, et al.
Biological Psychiatry|January 27, 2023
Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant DepressionBalwinder Singh, Jennifer L Vande Voort, Patricio Riva-Posse, et al.
Public Health Genomics|March 3, 2021
Motivating and Discouraging Factors for Bipolar Patient Participation in Genomic ResearchEric J Vallender, Mark E Ladner, Margaret O Akinhanmi, et al.
Depression and Anxiety|April 11, 2016
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICEWilliam V Bobo, Jennifer L Vande Voort, Paul E Croarkin, et al.
Psychiatry Research|June 23, 2022
Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating studyBalwinder Singh, Siamak MahmoudianDehkordi, Jennifer L Vande Voort, et al.
Psychopharmacology Bulletin|January 2, 2025
Persistence of Lithium Underutilization in Patients of African Ancestry with Bipolar DisorderMonica J Taylor-Desir, Jorge A Sanchez-Ruiz, Eric J Vallender, et al.
Eating Behaviors|December 11, 2020
Symptoms of bipolar disorder are associated with lower bariatric surgery completion rates and higher food addictionAllison A Holgerson, Matthew M Clark, Mark A Frye, et al.
Bipolar Disorders|January 10, 2003
Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on designBarbara Hummel, Joerg Walden, Robert Stampfer, et al.
Pageof 52

Showing results (151-160 of 518) with videos related to

Sort By:
Pageof 52
The Journal of Clinical Psychiatry|November 15, 2011
International consensus group on depression prevention in bipolar disorderMark A Frye, Kyooseob Ha, Shigenobu Kanba, et al.
Journal of Clinical Psychopharmacology|August 22, 2013
A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depressionMark A Frye, Jon O Ebbert, Courtney A Prince, et al.
Biology of Sex Differences|December 11, 2019
Statistical methods for testing X chromosome variant associations: application to sex-specific characteristics of bipolar disorderWilliam A Jons, Colin L Colby, Susan L McElroy, et al.
Biological Psychiatry|January 27, 2023
Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant DepressionBalwinder Singh, Jennifer L Vande Voort, Patricio Riva-Posse, et al.
Public Health Genomics|March 3, 2021
Motivating and Discouraging Factors for Bipolar Patient Participation in Genomic ResearchEric J Vallender, Mark E Ladner, Margaret O Akinhanmi, et al.
Depression and Anxiety|April 11, 2016
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICEWilliam V Bobo, Jennifer L Vande Voort, Paul E Croarkin, et al.
Psychiatry Research|June 23, 2022
Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating studyBalwinder Singh, Siamak MahmoudianDehkordi, Jennifer L Vande Voort, et al.
Psychopharmacology Bulletin|January 2, 2025
Persistence of Lithium Underutilization in Patients of African Ancestry with Bipolar DisorderMonica J Taylor-Desir, Jorge A Sanchez-Ruiz, Eric J Vallender, et al.
Eating Behaviors|December 11, 2020
Symptoms of bipolar disorder are associated with lower bariatric surgery completion rates and higher food addictionAllison A Holgerson, Matthew M Clark, Mark A Frye, et al.
Bipolar Disorders|January 10, 2003
Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on designBarbara Hummel, Joerg Walden, Robert Stampfer, et al.
Pageof 52